Among endometrial cancer cell lines, HEC-1 cells, which overexpress PXR and underexpress ER and progesterone receptor, show a stronger transcriptional response of the PXR–CYP3A pathway to ligands of PXR [355]. This evidence concerns the gene NR1I2 and endometrial cancer.